Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT01937117
Title Pertuzumab and Trastuzumab as Neoadjuvant Treatment in Patients With HER2-Positive Breast Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Sidney Kimmel Comprehensive Cancer Center
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
University of Alabama Comprehensive Cancer Center Birmingham Alabama 35294 United States Details
Johns Hopkins Kimmel Cancer Center at Sibley Memorial Hospital Washington District of Columbia 20016 United States Details
Indiana University Simon Cancer Center Indianapolis Indiana 46202 United States Details
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore Maryland 21287-0013 United States Details
Mayo Clinic Rochester Minnesota 55905 United States Details
Lineberger Comprehensive Cancer Center Chapel Hill North Carolina 27599 United States Details
Vanderbilt University Nashville Tennessee 37232 United States Details
Baylor College of Medicine Houston Texas 77030 United States Details
The University of Texas MD Anderson Cancer Center Houston Texas 77030 United States Details
Fred Hutchinson Cancer Research Center - University of Washington Seattle Washington 98109 United States Details
*Shaded cells indicate that there was no data available from for the field